Suppr超能文献

乳腺癌肿瘤疫苗

Tumor vaccines for breast cancer.

作者信息

Anderson Karen S

机构信息

Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

出版信息

Cancer Invest. 2009 May;27(4):361-8. doi: 10.1080/07357900802574421.

Abstract

The goal of cancer vaccines and immunotherapies is to train the immune system to recognize cancer cells and destroy them. Immune responses play a dynamic role in the development of cancers, from immunosurveillance to immune escape; from in situ immune dysregulation to metastatic spread. The systematic identification and targeting of molecules involved in the immune response has led to a wide variety of potential immunotherapeutic targets for the treatment of breast cancer. Extraordinary advances in molecular immunology have led to a detailed understanding of tumor antigens, antigen presentation, innate immunity, cytokine and chemokine pathways, and immunoregulation. Many of these vaccine therapies are already in clinical development. It is the rational and rapid translation of these scientific discoveries into effective therapies for patients with breast cancer that poses the greatest challenge, and opportunity, to realize the potential of tumor vaccine therapy for breast cancer.

摘要

癌症疫苗和免疫疗法的目标是训练免疫系统识别并摧毁癌细胞。免疫反应在癌症发展过程中发挥着动态作用,从免疫监视到免疫逃逸;从原位免疫失调到转移扩散。对免疫反应中涉及分子的系统识别和靶向作用,已产生了多种用于治疗乳腺癌的潜在免疫治疗靶点。分子免疫学的非凡进展使人们对肿瘤抗原、抗原呈递、固有免疫、细胞因子和趋化因子途径以及免疫调节有了详细的了解。其中许多疫苗疗法已处于临床开发阶段。将这些科学发现合理、快速地转化为针对乳腺癌患者的有效疗法,是实现肿瘤疫苗治疗乳腺癌潜力所面临的最大挑战,也是最大机遇。

相似文献

1
Tumor vaccines for breast cancer.
Cancer Invest. 2009 May;27(4):361-8. doi: 10.1080/07357900802574421.
2
Cancer vaccines: finding the best way to train the immune system.
J Natl Cancer Inst. 2002 Oct 16;94(20):1523-6. doi: 10.1093/jnci/94.20.1523.
4
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].
Ann Pathol. 2017 Feb;37(1):133-141. doi: 10.1016/j.annpat.2016.12.012. Epub 2017 Jan 31.
5
Immunizing against breast cancer: a new swing for an old sword.
Breast. 2009 Oct;18 Suppl 3:S51-4. doi: 10.1016/S0960-9776(09)70273-5.
6
HER2 dendritic cell vaccines.
Clin Breast Cancer. 2003 Feb;3 Suppl 4:S164-72. doi: 10.3816/cbc.2003.s.007.
7
Dendritic cell-based vaccines in patients with hematological malignancies.
Ann N Y Acad Sci. 2001 Jun;938:359-62; discussion 362-3. doi: 10.1111/j.1749-6632.2001.tb03603.x.
8
[Anti-HER2 vaccines: The HER2 immunotargeting future?].
Pathol Biol (Paris). 2011 Jun;59(3):173-82. doi: 10.1016/j.patbio.2009.04.002. Epub 2009 May 28.

引用本文的文献

1
Dendritic Cells in Cancer Immunology and Immunotherapy.
Cancers (Basel). 2024 Feb 28;16(5):981. doi: 10.3390/cancers16050981.
3
Cancer immunotherapy: a promising dawn in cancer research.
Am J Blood Res. 2020 Dec 15;10(6):375-385. eCollection 2020.
4
Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer.
Int J Mol Sci. 2021 Jan 14;22(2):779. doi: 10.3390/ijms22020779.
7
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.
Oncol Lett. 2016 Oct;12(4):2271-2276. doi: 10.3892/ol.2016.5001. Epub 2016 Aug 11.
8
Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.
Gene Ther. 2016 Dec;23(12):839-845. doi: 10.1038/gt.2016.63. Epub 2016 Aug 24.
9
The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.
Integr Cancer Ther. 2017 Sep;16(3):319-328. doi: 10.1177/1534735416651492. Epub 2016 Jun 1.
10
Immunotherapy for the treatment of breast cancer.
Curr Oncol Rep. 2015 Feb;17(2):5. doi: 10.1007/s11912-014-0426-9.

本文引用的文献

2
Inflammatory chemokines in cancer growth and progression.
Eur J Cancer. 2006 Apr;42(6):760-7. doi: 10.1016/j.ejca.2006.01.002. Epub 2006 Feb 28.
3
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.
Semin Cancer Biol. 2006 Apr;16(2):124-36. doi: 10.1016/j.semcancer.2005.11.006. Epub 2006 Jan 26.
4
Functional control of regulatory T cells and cancer immunotherapy.
Semin Cancer Biol. 2006 Apr;16(2):106-14. doi: 10.1016/j.semcancer.2005.11.004. Epub 2006 Jan 19.
6
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
J Clin Invest. 2005 Dec;115(12):3623-33. doi: 10.1172/JCI25947. Epub 2005 Nov 23.
7
Regulatory T cells in ovarian cancer: biology and therapeutic potential.
Am J Reprod Immunol. 2005 Dec;54(6):369-77. doi: 10.1111/j.1600-0897.2005.00330.x.
9
Autoantibody signatures in prostate cancer.
N Engl J Med. 2005 Sep 22;353(12):1224-35. doi: 10.1056/NEJMoa051931.
10
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
Cancer Res. 2005 Sep 15;65(18):8059-64. doi: 10.1158/0008-5472.CAN-05-1797.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验